| UHC Commercial Medical & Drug | Evkeeza® (Evinacumab-Dgnb) – Commercial Medical Benefit Drug Policy | 2026-04-01 |
| UHC Commercial Medical & Drug | Home Traction Therapy – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC Commercial Medical & Drug | Leqembi® (Lecanemab-Irmb) – Commercial Medical Benefit Drug Policy | 2026-04-01 |
| UHC Commercial Medical & Drug | Oncology Medication Clinical Coverage – Commercial Medical Benefit Drug Policy | 2026-04-01 |
| UHC Commercial Medical & Drug | Papzimeos™ (Zopapogene Imadenovec-Drba) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-04-01 |
| UHC Commercial Medical & Drug | Repository Corticotropin Injections – Commercial Medical Benefit Drug Policy | 2026-04-01 |
| UHC Commercial Medical & Drug | Rhinoplasty and Other Nasal Procedures – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC Commercial Medical & Drug | Uplizna® (Inebilizumab-Cdon) – Commercial Medical Benefit Drug Policy | 2026-04-01 |
| UHC Commercial Medical & Drug | Upper Extremity Prosthetic Devices – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC Commercial Medical & Drug | Vertebral Body Tethering for Scoliosis – Commercial and Individual Exchange Medical Policy | 2026-04-01 |